ABEO 8.060 € (+1,51 %)
SAFRAN 282.400 € (-6,80 %)
HOPIUM 0.008 € (-2,44 %)
BE SEMICONDUCTOR 227.900 € (+0,40 %)
GENFIT 8.900 € (-2,41 %)
SHELL PLC 37.695 € (+0,24 %)
STMICROELECTRONICS 37.610 € (+0,90 %)
EXOR NV 70.000 € (-0,28 %)
SANOFI 81.020 € (-1,23 %)
LVMH 486.000 € (-0,93 %)
UMG 20.080 € (-1,47 %)
KERING 243.200 € (-2,01 %)
MR BRICOLAGE 4.670 € (-1,68 %)
CARREFOUR 16.710 € (-0,54 %)
AIRBUS 170.520 € (-1,54 %)
AXA 42.420 € (-0,07 %)
FLEURY MICHON 22.300 € (0,00 %)
AALBERTS NV 31.440 € (-0,69 %)
TIKEHAU CAPITAL 19.200 € (-2,34 %)
FASTNED 29.800 € (+5,11 %)
JCDECAUX 19.230 € (-3,42 %)
ATOS 36.240 € (-2,74 %)
NANOBIOTIX 26.340 € (-5,05 %)
SARTORIUS STED BIO 188.500 € (+0,96 %)
LEGRAND 147.750 € (-0,54 %)
SOITEC 100.750 € (+0,75 %)
ARKEMA 61.600 € (-0,65 %)
CSG 21.040 € (-0,82 %)
ACCOR 44.340 € (-2,27 %)
UNIBAIL-RODAMCO-WE 104.750 € (-0,62 %)
AIR FRANCE -KLM 9.896 € (-3,50 %)
BIOMERIEUX 90.600 € (+0,50 %)
ADOCIA 5.720 € (+16,83 %)
ABN AMRO BANK N.V. 30.200 € (+0,33 %)
MANITOU BF 21.750 € (+1,64 %)
BOLLORE 5.080 € (+1,09 %)
CRCAM ILLE-VIL.CCI 116.120 € (+0,66 %)
CTP 16.100 € (-1,35 %)
GROUPE OKWIND 1.200 € (+36,36 %)
BENETEAU 7.100 € (-1,11 %)
ABIVAX 98.000 € (-2,58 %)
BNP PARIBAS ACT.A 92.140 € (-0,50 %)
BASIC-FIT 31.460 € (-0,57 %)
CIECHARGEURSINVEST 8.500 € (0,00 %)
THALES 247.700 € (-5,92 %)
Coca-ColaEuropacif 82.100 € (-1,20 %)
SPIE 46.460 € (-1,27 %)
TECHNIP ENERGIES 39.420 € (-0,15 %)
SCHNEIDER ELECTRIC 272.100 € (-0,55 %)
ING GROEP N.V. 24.495 € (0,00 %)
ALSTOM 17.050 € (-0,20 %)
GECINA 72.400 € (-0,21 %)
EDENRED 20.620 € (+1,53 %)
BOUYGUES 52.200 € (-0,53 %)
UNILEVER 48.705 € (-1,23 %)
VALEO 11.120 € (-1,20 %)
REXEL 36.750 € (-1,63 %)
ELIS 26.580 € (-0,97 %)
TKH GROUP 42.360 € (-0,33 %)
EURONEXT 146.600 € (-0,07 %) |
21/04/2026 19:15
AXA - Description of the Company’s share repurchase programParis, April 21, 2026 Description of the Company’s share repurchase programPursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of the description below is to set out the objectives and terms of AXA’s (the “Company”) share repurchase program that will be submitted for shareholder approval at AXA’s Ordinary Shareholders’ Meeting to be held on April 30, 2026. Date of the Shareholders’ Meeting convened to authorize the program: Treasury shares held on March 31, 2026:
Objectives of the Company’s share repurchase program:Pursuant to the provisions of the European Commission Regulation n° 596/2014 of April 16, 2014, the Commission Delegated Regulation n° 2016/1052 of March 8, 2016 and in accordance with market practices accepted by the AMF, the objectives of the Company’s share repurchase program to be submitted to the shareholders for approval on April 30, 2026 are the following:
Maximum percentage of share capital and maximum number of shares that may be repurchased by the Company and maximum purchase price:
Term of the repurchase program18 months from the date of the Shareholders’ Meeting to be held on April 30, 2026, subject to approval of the program by the shareholders. * * * ABOUT THE AXA GROUPThe AXA Group is a worldwide leader in insurance, with 156,000 employees serving 92 million clients in 52 countries. In 2025, IFRS17 revenues amounted to Euro 115.5 billion and IFRS17 underlying earnings to Euro 8.4 billion. The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA’s American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY. The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD. It is a founding member of the UN Environment Programme’s Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment. This press release and the regulated information made public by AXA pursuant to article L. 451-1-2 of the French Monetary and Financial Code and articles 222-1 et seq. of the Autorité des marchés financiers’ General Regulation are available on the AXA Group website (axa.com). THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE axa.com FOR MORE INFORMATION:Investor Relations: +33.1.40.75.48.42 Individual Shareholder Relations: Media Relations: +33.1.40.75.46.74 Corporate Responsibility strategy: SRI ratings: Notes
Source : Webdisclosure.com |
||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière